Avid Bioservices Inc (CDMO)

[entdoc]

spankyvol, agreed, the biggest "short-term driver" is the MOS(months of survival in advanced cancer patients using Bavituximab) which has not yet been reached when it was reached in [previous!]standard of care therapy months ago. What newcomers are not aware of is all the criticism of PPHM execs for their underspoken approach to accomplishments. That criticism here has been muted for about 6 weeks now, but will undoubtedly start once again. Once upon a time there were so-called "ethical pharmaceutical houses"...Parke-Davis, Lily, Merck...before Pfizer, BW, etc. existed--ethical because of their studied restraint re. unfounded claims. I consider PPHM's executive suite to be guided by ethical considerations and restraints, and respect them for it. The past two weeks have seen the only glimse of well-deserved and rational exuberance.